Value of Cardiac Magnetic Resonance (CMR) Derived Parameters for Diagnosing Left Ventricular Non-compaction Cardiomyopathy

NCT ID: NCT01481298

Last Updated: 2011-11-29

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 57 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2004-12-31
• Study Completion Date: 2008-10-31

Brief Summary

Left ventricular non-compaction (LVNC) is a rare cardiomyopathy characterized by numerous excessively prominent left ventricular (LV) trabeculation and deep intertrabecular recesses communicating with the ventricular cavity and severely altering myocardial structure. Although most authors assume a developmental arrest in embryogenesis as the underlying pathology, the mechanisms of LVNC are not fully understood yet. Several gene mutations have been identified to be linked with LVNC and an autosomal dominant inheritance pattern is frequent To date the most commonly used imaging tool for diagnosing LVNC is echocardiography applying the criteria established by Jenni and coauthors However, qualitative parameters to differentiate normal compaction of the myocardium in healthy subjects from LVNC or from other cardiomyopathies like dilative cardiomyopathy (DCM) or hypertrophic cardiomyopathy (HCM) may fail due to highly variable LV trabeculation. Therefore, absolute quantification should be performed. Cardiac magnetic resonance (CMR) has been reported as a promising imaging modality to characterize patients with LVNC as it provides both a high spatial resolution and a good contrast between trabeculation and blood pool Jacquier et al. recently described a value of trabeculated LV myocardial mass above 20% of the global mass of the LV to be highly sensitive and specific for LVNC However, in their approach, a substantial degree of the LV cavity was included into calculated trabecular LV mass and led to systemic overestimation of the latter. Furthermore, the role and prognostic value of myocardial scarring as assessed by delayed enhancement (DE) CMR was not evaluated.

The aim of the retrospective study was to establish revised and extended CMR criteria to distinguish LVNC from DCM, HCM and a group of healthy controls and to improve the assessment of trabeculated mass by excluding intertrabecular blood pool.

Conditions

Left Ventricular Non-compaction Cardiomyopathy; Left Ventricular Failure; Left Ventricular Hypertrophy

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: RETROSPECTIVE

Study Groups

LVNC

12 patients with left ventricular non-compaction cardiomyopathy

No interventions assigned to this group

HCM

10 patients with hypertrophic cardiomyopathy

No interventions assigned to this group

DCM

11 patients with dilatative cardiomyopathy

No interventions assigned to this group

controls

24 healthy controls

No interventions assigned to this group

Eligibility Criteria

Inclusion Criteria

• left ventricular non-compaction cardiomyopathy
• dilatative cardiomyopathy
• hypertrophic cardiomyopathy or healty controls

Exclusion Criteria

• contraindications for magnetic resonance imaging like pacemakers or other metallic implants

• Minimum Eligible Age: 14 Years
• Maximum Eligible Age: 64 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

University of Leipzig

OTHER

Sponsor Role: lead

Responsible Party

Matthias Grothoff, M.D.

Dr. med.

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

University of Leipzig - Heart Center

Leipzig, , Germany

Countries

Germany

Other Identifiers

LVNC 2011

Identifier Type: -

Identifier Source: org_study_id